Keith Katkin, a director at Emergent BioSolutions, has executed a sale of company stock valued at $128,182. This transaction reflects a portion of his holdings in the company, although specific details regarding the number of shares sold or the reasons for the sale have not been disclosed. The sale is part of routine stock trading activities by company insiders, which are typically reported to regulatory authorities.
Related Articles
.jpeg)
Don't miss out on breaking stories and in-depth articles.